Correlation Between Microsoft and Rossari Biotech

Can any of the company-specific risk be diversified away by investing in both Microsoft and Rossari Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Rossari Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Microsoft and Rossari Biotech Limited, you can compare the effects of market volatilities on Microsoft and Rossari Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Rossari Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Rossari Biotech.

Diversification Opportunities for Microsoft and Rossari Biotech

-0.03

Correlation Coefficient

Microsoft  Rossari Biotech

Good diversification

The 3 months correlation between Microsoft and Rossari is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Rossari Biotech Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rossari Biotech and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Rossari Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rossari Biotech has no effect on the direction of Microsoft i.e., Microsoft and Rossari Biotech go up and down completely randomly.

Pair Corralation between Microsoft and Rossari Biotech

Given the investment horizon of 90 days Microsoft is expected to under-perform the Rossari Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Microsoft is 1.45 times less risky than Rossari Biotech. The stock trades about -0.03 of its potential returns per unit of risk. The Rossari Biotech Limited is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  84,519  in Rossari Biotech Limited on September 29, 2024 and sell it today you would lose (4,824) from holding Rossari Biotech Limited or give up 5.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.21%
Values	Daily Returns

Microsoft  vs.  Rossari Biotech Limited

Microsoft

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Microsoft has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Rossari Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rossari Biotech Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pair Trading with Microsoft and Rossari Biotech

The main advantage of trading using opposite Microsoft and Rossari Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Rossari Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rossari Biotech will offset losses from the drop in Rossari Biotech's long position.

The idea behind Microsoft and Rossari Biotech Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.